Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

1.2K
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
1.2K
Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

1.1K
Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
1.1K
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

541
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
541
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

745
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
745
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

1.2K
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
1.2K
Mucosal Barrier of the Stomach01:25

Mucosal Barrier of the Stomach

2.0K
The gastric glands contain parietal cells that secrete hydrochloric acid (HCl) for digestion. The cells secrete HCl because it is highly corrosive and essential for breaking down food. To achieve this, they secrete hydrogen and chloride ions into the lumen of the gastric glands, which combine to form HCl.
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
2.0K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Review Article: Implementation Challenges in Helicobacter pylori Management: Bridging Evidence and Real-World Practice.

Alimentary pharmacology & therapeutics·2026
Same author

Deletion of endothelial SOX9 reverses aging-induced cardiac dysfunction.

Cardiovascular research·2026
Same author

Elucidating the Pathogenic Role of Helicobacter pylori Infection in Hematologic Disorders: Mechanistic Insights and Future Perspectives.

Helicobacter·2026
Same author

CCR2<sup>+</sup> Neutrophils Exhibit a Proinflammatory Phenotype and Contribute to Plaque Vulnerability.

Arteriosclerosis, thrombosis, and vascular biology·2026
Same author

Author Correction: The AIM2 inflammasome exacerbates atherosclerosis in clonal haematopoiesis.

Nature·2026
Same author

Deletion of PKM2 in Macrophages Promotes Stabilization but Not Regression of Atherosclerotic Plaques.

Circulation research·2026
Same journal

Innere Medizin (Heidelberg, Germany)·2026
Same journal

Innere Medizin (Heidelberg, Germany)·2026
Same journal

Innere Medizin (Heidelberg, Germany)·2026
Same journal

[Optimal blood pressure control in patients with diabetes and arterial hypertension: interpreting the BPROAD study].

Innere Medizin (Heidelberg, Germany)·2026
Same journal

[Distributive justice in healthcare during times of change: a medical ethics perspective].

Innere Medizin (Heidelberg, Germany)·2026
Same journal

[Update on the pharmacotherapy of chronic heart failure with reduced ejection fraction: from four to six pillars?]

Innere Medizin (Heidelberg, Germany)·2026
查看所有相关文章

相关实验视频

Updated: Jan 18, 2026

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
05:23

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance

Published on: March 7, 2025

741

[螺旋杆菌] [螺旋杆菌]

Christian Schulz1,2, Kerstin Schütte3,4

  • 1Medizinische Klinik und Poliklinik 2, LMU Klinikum München, Marchioninistr. 15, 81377, München, Deutschland. chr.schulz@med.uni-muenchen.de.

Innere Medizin (Heidelberg, Germany)
|September 9, 2025
PubMed
概括
此摘要是机器生成的。

建议在检测到Helicobacter pylori (H. pylori) 时进行根除. 抗生素耐药性增加需要更新H. pylori诊断和治疗的指导方针,包括敏感性测试考虑.

关键词:
杆菌/试验方法根除疗法是一种根除疗法.胃潰瘍/并發症胃潰瘍/危險因素胃的新生瘤 胃的新生瘤

更多相关视频

High Resolution Electron Microscopy of the Helicobacter pylori Cag Type IV Secretion System Pili Produced in Varying Conditions of Iron Availability
09:05

High Resolution Electron Microscopy of the Helicobacter pylori Cag Type IV Secretion System Pili Produced in Varying Conditions of Iron Availability

Published on: November 21, 2014

15.9K
Rapid Detection of Helicobacter pylori Virulence and Typing Using Quantum Dot Labeling Technology
05:13

Rapid Detection of Helicobacter pylori Virulence and Typing Using Quantum Dot Labeling Technology

Published on: June 13, 2025

737

相关实验视频

Last Updated: Jan 18, 2026

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
05:23

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance

Published on: March 7, 2025

741
High Resolution Electron Microscopy of the Helicobacter pylori Cag Type IV Secretion System Pili Produced in Varying Conditions of Iron Availability
09:05

High Resolution Electron Microscopy of the Helicobacter pylori Cag Type IV Secretion System Pili Produced in Varying Conditions of Iron Availability

Published on: November 21, 2014

15.9K
Rapid Detection of Helicobacter pylori Virulence and Typing Using Quantum Dot Labeling Technology
05:13

Rapid Detection of Helicobacter pylori Virulence and Typing Using Quantum Dot Labeling Technology

Published on: June 13, 2025

737

科学领域:

  • 微生物学 微生物学
  • 传染性疾病 传染性疾病
  • 胃肠病学 胃肠病学

背景情况:

  • 杆菌 (H. pylori) 在1983年被确定为病原体.
  • 在了解H. pylori病理生理学,诊断和治疗方面取得了重大进展.
  • 杆菌感染与胃恶性瘤有关,需要根除治疗.

研究的目的:

  • 提供H. pylori临床相关性的概述.
  • 解释当前基于指南的诊断指示和方法.
  • 在抗生素耐药性增加的情况下讨论治疗策略.

主要方法:

  • 对H. pylori管理的临床指南和文献的审查.
  • 对H. pylori检测的诊断方法的分析.
  • 评估治疗选择和抗菌素耐药性模式.

主要成果:

  • 与H. pylori相关的胃炎是一种需要根除的传染病.
  • 抗生素耐药性增加影响了第一线治疗建议.
  • 关于治疗前的常规抗菌素敏感性测试存在争议.

结论:

  • 更新的临床指南反映了H. pylori抗生素耐药性所带来的挑战.
  • 基于指南的诊断和治疗对于有效的H. pylori管理至关重要.
  • 需要进一步研究优化H. pylori治疗策略在耐药性的背景下.